Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma

<p>Abstract</p> <p>Background</p> <p>Atrial natriuretic peptide (ANP) and its receptor, NPRA, have been extensively studied in terms of cardiovascular effects. We have found that the ANP-NPRA signaling pathway is also involved in airway allergic inflammation and asthma....

Full description

Bibliographic Details
Main Authors: Cormier Stephania A, Giaimo Joseph D, Ahlert Terry A, Hellermann Gary, Chen Dongqing, Kong Xiaoyuan, Xu Weidong, Wang Xiaoqin, Li Xu, Lockey Richard F, Mohapatra Subhra, Mohapatra Shyam S
Format: Article
Language:English
Published: BMC 2009-07-01
Series:Respiratory Research
Online Access:http://respiratory-research.com/content/10/1/66
_version_ 1818117705490759680
author Cormier Stephania A
Giaimo Joseph D
Ahlert Terry A
Hellermann Gary
Chen Dongqing
Kong Xiaoyuan
Xu Weidong
Wang Xiaoqin
Li Xu
Lockey Richard F
Mohapatra Subhra
Mohapatra Shyam S
author_facet Cormier Stephania A
Giaimo Joseph D
Ahlert Terry A
Hellermann Gary
Chen Dongqing
Kong Xiaoyuan
Xu Weidong
Wang Xiaoqin
Li Xu
Lockey Richard F
Mohapatra Subhra
Mohapatra Shyam S
author_sort Cormier Stephania A
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Atrial natriuretic peptide (ANP) and its receptor, NPRA, have been extensively studied in terms of cardiovascular effects. We have found that the ANP-NPRA signaling pathway is also involved in airway allergic inflammation and asthma. ANP, a C-terminal peptide (amino acid 99–126) of pro-atrial natriuretic factor (proANF) and a recombinant peptide, NP73-102 (amino acid 73–102 of proANF) have been reported to induce bronchoprotective effects in a mouse model of allergic asthma. In this report, we evaluated the effects of vessel dilator (VD), another N-terminal natriuretic peptide covering amino acids 31–67 of proANF, on acute lung inflammation in a mouse model of allergic asthma.</p> <p>Methods</p> <p>A549 cells were transfected with pVD or the pVAX1 control plasmid and cells were collected 24 hrs after transfection to analyze the effect of VD on inactivation of the extracellular-signal regulated receptor kinase (ERK1/2) through western blot. Luciferase assay, western blot and RT-PCR were also performed to analyze the effect of VD on NPRA expression. For determination of VD's attenuation of lung inflammation, BALB/c mice were sensitized and challenged with ovalbumin and then treated intranasally with chitosan nanoparticles containing pVD. Parameters of airway inflammation, such as airway hyperreactivity, proinflammatory cytokine levels, eosinophil recruitment and lung histopathology were compared with control mice receiving nanoparticles containing pVAX1 control plasmid.</p> <p>Results</p> <p>pVD nanoparticles inactivated ERK1/2 and downregulated NPRA expression in vitro, and intranasal treatment with pVD nanoparticles protected mice from airway inflammation.</p> <p>Conclusion</p> <p>VD's modulation of airway inflammation may result from its inactivation of ERK1/2 and downregulation of NPRA expression. Chitosan nanoparticles containing pVD may be therapeutically effective in preventing allergic airway inflammation.</p>
first_indexed 2024-12-11T04:42:39Z
format Article
id doaj.art-bf5e23ed874f4d5d9633f187aaff0292
institution Directory Open Access Journal
issn 1465-9921
language English
last_indexed 2024-12-11T04:42:39Z
publishDate 2009-07-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-bf5e23ed874f4d5d9633f187aaff02922022-12-22T01:20:35ZengBMCRespiratory Research1465-99212009-07-011016610.1186/1465-9921-10-66Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthmaCormier Stephania AGiaimo Joseph DAhlert Terry AHellermann GaryChen DongqingKong XiaoyuanXu WeidongWang XiaoqinLi XuLockey Richard FMohapatra SubhraMohapatra Shyam S<p>Abstract</p> <p>Background</p> <p>Atrial natriuretic peptide (ANP) and its receptor, NPRA, have been extensively studied in terms of cardiovascular effects. We have found that the ANP-NPRA signaling pathway is also involved in airway allergic inflammation and asthma. ANP, a C-terminal peptide (amino acid 99–126) of pro-atrial natriuretic factor (proANF) and a recombinant peptide, NP73-102 (amino acid 73–102 of proANF) have been reported to induce bronchoprotective effects in a mouse model of allergic asthma. In this report, we evaluated the effects of vessel dilator (VD), another N-terminal natriuretic peptide covering amino acids 31–67 of proANF, on acute lung inflammation in a mouse model of allergic asthma.</p> <p>Methods</p> <p>A549 cells were transfected with pVD or the pVAX1 control plasmid and cells were collected 24 hrs after transfection to analyze the effect of VD on inactivation of the extracellular-signal regulated receptor kinase (ERK1/2) through western blot. Luciferase assay, western blot and RT-PCR were also performed to analyze the effect of VD on NPRA expression. For determination of VD's attenuation of lung inflammation, BALB/c mice were sensitized and challenged with ovalbumin and then treated intranasally with chitosan nanoparticles containing pVD. Parameters of airway inflammation, such as airway hyperreactivity, proinflammatory cytokine levels, eosinophil recruitment and lung histopathology were compared with control mice receiving nanoparticles containing pVAX1 control plasmid.</p> <p>Results</p> <p>pVD nanoparticles inactivated ERK1/2 and downregulated NPRA expression in vitro, and intranasal treatment with pVD nanoparticles protected mice from airway inflammation.</p> <p>Conclusion</p> <p>VD's modulation of airway inflammation may result from its inactivation of ERK1/2 and downregulation of NPRA expression. Chitosan nanoparticles containing pVD may be therapeutically effective in preventing allergic airway inflammation.</p>http://respiratory-research.com/content/10/1/66
spellingShingle Cormier Stephania A
Giaimo Joseph D
Ahlert Terry A
Hellermann Gary
Chen Dongqing
Kong Xiaoyuan
Xu Weidong
Wang Xiaoqin
Li Xu
Lockey Richard F
Mohapatra Subhra
Mohapatra Shyam S
Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma
Respiratory Research
title Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma
title_full Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma
title_fullStr Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma
title_full_unstemmed Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma
title_short Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma
title_sort modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma
url http://respiratory-research.com/content/10/1/66
work_keys_str_mv AT cormierstephaniaa modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT giaimojosephd modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT ahlertterrya modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT hellermanngary modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT chendongqing modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT kongxiaoyuan modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT xuweidong modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT wangxiaoqin modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT lixu modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT lockeyrichardf modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT mohapatrasubhra modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma
AT mohapatrashyams modulationoflunginflammationbyvesseldilatorinamousemodelofallergicasthma